
Verrica Reports Strong Q2 Growth as YCANTH Demand Accelerates
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) announced a significant surge in demand for its lead product, YCANTH®, in the second quarter of 2025, reporting 13,434 dispensed applicator …
Verrica Reports Strong Q2 Growth as YCANTH Demand Accelerates Read More